BridgeBio Pharma (BBIO) PT Raised to $110 at TD Cowen
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $74.67 -0.23%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $110.00 (from $95.00) while maintaining a Buy rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Tarsus Pharmaceuticals (TARS) PT Raised to $105 at Jefferies
- JPMorgan Upgrades Telekom Malaysia Bhd (T:MK) (MYTEF) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
